数字 Accessory Bronchus 副気管支 Accessory Fissure 副葉間裂

Total Page:16

File Type:pdf, Size:1020Kb

数字 Accessory Bronchus 副気管支 Accessory Fissure 副葉間裂 数字 accentuation 亢進 accessory 副の 数字 accessory bronchus 副気管支 accessory fissure 副葉間裂 10-year survival 10年生存 accessory lobe 副肺葉 18F-fluorodeoxy glucose (FDG) 18F-フルオロデオキシグルコース accessory lung 副肺 2,3-diphosphoglycerate (2,3-DPG) 2,3ジフォスフォグリセレート accessory nasal sinus 副鼻腔 201TI (thallium-201) タリウム accessory trachea 副気管 5-fluorouracil(FU) 5-フルオロウラシル acclimation 順化 5-HT3 receptor antagonist 5-HT3レセプター拮抗薬 acclimation 馴化 5-hydroxytryptamine 5-ヒドロオキシトリプタミン acclimatization 気候順応 5-year survival 5年生存 acclimatization 順化 99mTc-macroaggregated albumin (99mTc-MAA) 99mTc標識大 acclimatization 馴化 凝集アルブミン accommodation 順応 accommodation 調節 accommodation to high altitude 高所順(適)応 A ACE polymorphism ACE遺伝子多型 acetone body アセトン体 abdomen 腹部 acetonuria アセトン尿[症] abdominal 腹部[側]の acetylcholine(ACh) アセチルコリン abdominal breathing 腹式呼吸 acetylcholine receptor (AchR, AChR) アセチルコリン受容体(レセプ abdominal cavity 腹腔 ター) abdominal pressure 腹腔内圧 acetylcholinesterase (AchE, AChE) アセチルコリンエステラーゼ abdominal respiration 腹式呼吸 achalasia アカラシア abdominal wall reflex 腹壁反射 achalasia 弛緩不能症 abduction 外転 achalasia [噴門]無弛緩[症] aberrant 走性 achromatocyte (achromocyte) 無血色素[赤]血球 aberrant 迷入性 achromatocyte (achromocyte) 無へモグロビン[赤]血球 aberrant artery 迷入動脈 acid 酸 aberration 迷入 acid 酸性 ablation 剥離 acid base equilibrium 酸塩基平衡 abnormal breath sound(s) 異常呼吸音 acid fast 抗酸性の abortive 早産の acid fast bacillus 抗酸菌 abortive 頓挫性(型) acid-base 酸―塩基 abortive 不全型 acid-base balance 酸塩基平衡 abortive pneumonia 頓挫[性]肺炎 acid-base disturbance 酸塩基平衡異常 abrasion 剥離 acid-base equilibrium 酸塩基平衡 abscess 膿瘍 acid-base regulation 酸塩基調節 absolute arrhythmia 絶対[性]不整脈 acidemia アシデミア absolute cardiac dullness 絶対[的]心濁音界 acidemia 酸[性]血症 absorption 吸収[作用] acid-fast stain(s) 抗酸[性]染色[法] acanthoma 棘細胞腫 acidity 酸[性]度 acanthosis [有]棘細胞症 acidophil 好酸性 accelerated fractionation 加速分割照射 acidoresistant 耐(抗)酸性の acceleration 加速化現象 acidosis アシドーシス acceleration 加速度[現象] acinar 細葉[性]の - 1 - - 2 - 10501657_用語集_英和.indd 1 2017/05/01 14:50:52 Acinetobacter アシネトバクター acute pulmonary thromboembolism 急性肺血栓塞栓症 Acinetobacter pneunomia アシネトバクター肺炎 acute respiratory distress syndrome (ARDS) 急性呼吸窮(促)迫 acinus 腺房 症候群 acinus [肺の]細葉 acute respiratory distress syndrome(ARDS) 成人呼吸促(窮)迫 acinus 胞 症候群 acoustic impedance 音響インピーダンス acute-phase response 急性期反応 acquired 獲得[性]の Adamkiewicz artery アダムキーヴィッツ動脈 acquired 後天性(的) Adams-Stokes syndrome アダムス・ストークス症候群 acquired immunity 獲得免疫 adaptation 順応 acquired immunity 後天性免疫 adaptation 適応 acquired immunodeficiency syndrome 後天性免疫不全症候群 adaptation 適合 acrocyanosis 先(肢)端チアノーゼ adaptation to environment 環境適応 acrocyanosis 指尖チアノーゼ adaptation to high altitude 高所順(適)応 acromegalia 先端巨大症 addict 耽溺する acromegaly 先端肥大症 addict [麻薬]常用者 ACTH test ACTHテスト Addison's disease アジソン病 ACTH-producing tumor ACTH産生腫瘍 additional tumor nodule 副腫瘍結節 actin アクチン adenectomy 腺切除[術] actinolite アクチノライト(石綿の一種) adenectomy 腺摘出[術] Actinomyces 放線[状]菌 adenitis 腺炎 actinomycosis 放線菌症 adenoacanthoma 腺棘細胞腫 action current 活動電流 adenoacanthoma 腺表皮癌 activate 賦活化(活性化)する adeno-associated virus (AAV) アデノ随伴ウイルス activation 活性(動)化 adenocarcinoma 腺癌 activation 賦活 adenofibroma 腺線維腫 activator アクチベーター adenofibrosis 腺線維症 activator 活性[化]薬 adenoid cystic carcinoma 腺様嚢胞癌 activator 賦活物質 adenoiditis 咽頭扁桃炎 activator protein-1 (AP-1) 活性化蛋白1 adenoma 腺腫 active 活[動]性の adenomatosis 腺腫症 active 能動的 adenomatous hyperplasia 腺[腫]様増殖 active immunity 能動免疫 adenomatous lung cancer 腺腫様肺癌 active transport 能動輸送 adenomatous metaplasia 腺[腫]様化生 activin receptor-like kinase アクチビン受容体様キナーゼ adenosin deaminase(ADA) アデノシンデアミナーゼ activity 活性 adenosine 5'-monophosphate アデノシン5'-一燐酸塩 activity 活動度 adenosine deaminase アデノシンデアミネース activity 活(能)動性 adenosine deaminase deficiency アデンシンデアミナーゼ欠損症 activity of daily living (ADL) 日常生活動作 adenosine triphosphate (ATP) アデノシン三リン酸 acute 急性(の) adenosquamous carcinoma of the lung 肺腺扁平上皮癌 acute bronchiolitis 急性細気管支炎 adenoviral gene therapy アデノウイルス遺伝子療法 acute bronchitis 急性気管支炎 adenoviral gene transfer アデノウイルス遺伝子移入 acute hypersensitivity pneumonia (AHP) 急性過敏性肺炎 adenoviral pneumonia アデノウイルス肺炎 acute lung injury 急性肺傷害 adenovirus アデノウイルス acute mountain sickness (AMS) 急性高山病 adenovirus infection アデノウイルス感染症 acute myocardial infarction (AMI) 急性心筋梗塞[症] adherence アドヒアランス acute pneumonia 急性肺炎 adherence factor(s) 接着因子 - 1 - - 2 - 10501657_用語集_英和.indd 2 2017/05/01 14:50:52 adhesion 癒着 aerial infection 空気感染(伝染) adhesion molecule 接着分子 aerobe 好気性菌 adhesion therapy 癒着療法 aerobic 好気性 adhesive atelectasis 癒着性無気肺 aerobic infection 好気[性]感染 adhesive pericarditis 癒着性心膜炎 aerobiosis 好気生活 adhesive pleurisy 癒着性胸膜炎 aerobiosis 有気生活 adipose tissue 脂肪組織 aeroembolism 空気塞栓[症] adjusted (standardized) death rate 訂正(標準化)死亡率 aerogen ガス産生菌 adjustment 適応 aerogenic ガス産生[性]の adjuvant アジュバント aerophagia 空気嚥下[症]、呑気[症] adjuvant 抗原(免疫) aerophagia 空気嚥下[症]、呑気[症] adjuvant 増強薬 aerophilous 好気性 adjuvant 補助剤 aeropiesotherapy 気圧療法 adjuvant chemo-immunotherapy アジュバント化学免疫療法 aerosol エアゾール adjuvant chemotherapy 補助化学療法 aerosol 噴霧 administration 適用 aerosol treatment (therapy) エアゾール療法 admission 入院 aerosolization エロゾ(ー)ル化 adnex 附属器 aerotherapy 大気療法 adnex 附属物 afebrile 無熱性 adolescence 青年期 afebrile 無熱の adoptive transfer 養子移入 afebrile pneumonia 無熱性肺炎 adrenal 副腎の affection 感情 adrenal cortex (cortex of suprarenal body) 副腎皮質 affection 情動 adrenal function 副腎機能 afferent 求心性 adrenal gland (suprarenal gland body) 腎小体 afferent 輸入 adrenal gland (suprarenal gland body) 腎上体 afferent fiber 求心性線維 adrenal gland (suprarenal gland body) 副腎 affinity 親和性 adrenal insufficiency 副腎不全[症] afibrinogenemia 無線維素原血症 adrenal metastasis 副腎転移 aflatoxin アフラトキシン adrenal suppression 副腎抑制 after birth、postnatal 後胚の adrenalectomy 副腎摘除(摘出)術 aftercare アフタケア adrenergic nerve アドレナリン[作動][性]神経 aftercare アフタケア,後療法 adrenocortical hormone (ACH) 副腎皮質ホルモン aftercare 後療法 adrenocorticotropic hormone (ACTH) 副腎皮質刺激ホルモン agammaglobulinemia 無γ(ガンマ)グロブリン血症 adrenomedulin アドレノメデュリン agar plate 寒天平板 adriamycin アドリアマイシン agenesis 無形成 adsorption 吸着[作用] agenesis 無発生 adult 成人 agglutination 凝集[作用] adult asthma 成人喘息 agglutination 凝集反応 advanced cancer 進行癌 agglutination 膠着 advanced lung cancer 進行肺癌 agglutinin 凝集素 adventitia [血管]外膜 agglutinoscope 凝集鏡 adventitious sound(s) 副雑音 agglutinoscope 凝集観察器 adynamic pneumonia 無力性肺炎 aggravation 悪化 aeration 含気 aggravation 増悪 aeration 通気 aging 加齢 - 3 - - 4 - 10501657_用語集_英和.indd 3 2017/05/01 14:50:52 aging 老化 airway closure 気道閉塞 aging lung 老人肺 airway collapse 気道虚脱 agitation 興奮 airway conductance 気道コンダクタンス agonal 死戦期の airway hyperreactivity 気道過敏性 agonal 瀕死期の airway hyperresponsiveness 気道過敏性 agonal respiration 死戦期呼吸 airway inflammation 気道炎症 agranulocytosis 無顆粒球症 airway narrowing 気道狭窄 AIDS(acquired immune deficiency syndrome) エイズ airway obstruction 気道閉塞 air 空気 airway occlusion pressure 気道閉塞圧 air alveologram 空気肺胞像 airway pressure 気道内圧 air blood barrier 空気血液関門 airway resistance 気道抵抗 air bronchogram 気管支透亮像 airway responsiveness 気道反応性 air cavity 気腔 airway stenosis 気道狭窄 air conditioner disease 空調病 airway vascularity 気道血管分布[像、状態] air conditioning 空気調節[法] airway wall remodeling 気道壁再構築 air conduction 気導 alarm reaction 警告反応 air conduction 空気伝導 alarm system 警告システム air dose 空中線量 alarm system 警報系統 air drift 空気流動 alarm system 警報装置 air embolism 空気塞栓[症] albumin アルブミン air embolism (aeroembolism) 空気塞栓[症] albuminuria 蛋白尿 air embolus 空気塞栓 alcohol アルコール air encephalogram (AEG) 気脳図(像) aldolase アルドラーゼ air flow 気流[量] aldosterone アルドステロン air flow limitation 気流制限 ALI(acute lung injury) 急性肺損傷 air hunger 空気飢餓[感] alimentarytract 消化管 air illness 気圧病 alkalemia アルカリ[性]血[症] air leak エアーリーク alkali アルカリ air leak 空気洩れ alkali reserve アルカリ予備量 air passage 通気[道] alkali reserve 予備アルカリ air pollution 大気汚染 alkaline アルカリ性の air space 気腔 alkaline phosphatase(ALP) アルカリ[性]フォスファターゼ air tamponade 空気タンポナーデ alkalinity アルカリ度 air trapping エアー(空気)・トラッピング alkalosis アルカローシス air trapping 空気とらえこみ alkylating アルキル化 airborne 空気を介した alkylating agent アルキル化薬 airborne infection 空気感染(伝染) allele アリル air-borne infection 空気感染(伝染) allelic loss アリル欠損 airflow 気流 allergen アレルゲン airflow limitation 気流制限 allergic アレルギー性 airflow obstruction 気流閉塞 allergic alveolitis アレルギー性胞隔炎 airflow resistance 気流抵抗 allergic asthma アレルギー[性]喘息 air-mask bag unit (AMBU-bag) アンビューバック allergic bronchitis アレルギー性気管支炎 airway エアウェイ allergic bronchopulmonary aspergillosis (ABPA) アレルギー性気 airway 気道 管支肺アスペルギルス症 airway caliber 気道[内]径 - 3 - - 4 - 10501657_用語集_英和.indd 4 2017/05/01 14:50:52 allergic bronchopulmonary mycosis (ABPM) アレルギー性気管支肺 alveolar dysplasia 肺胞形成異常[症] 真菌症 alveolar dysplasia 肺胞形成不全 allergic bronchopulmonary mycosis (ABPM) アレルギー性気管支肺 alveolar dysplasia 肺胞発育不全 真菌症 alveolar ectasia 肺胞拡張[症] allergic disease アレルギー性疾患 alveolar epithelial cell 肺胞上皮細胞 allergic granuloma アレルギー性肉芽腫 alveolar epithelium 肺胞上皮 allergic reaction アレルギー反応 alveolar gas 肺胞気 allergic rhinitis アレルギ一性鼻炎 alveolar gas equation 肺胞気式 allergic granulomatous angiitis (AGA) アレルギー性肉芽腫性血管炎 alveolar gas exchange 肺胞ガス交換 allergy アレルギー alveolar gas volume 肺胞気量 alloantigen 同種抗原 alveolar hypoventilation 肺胞低換気 allograft 同種(異型)移植(片) alveolar hypoventilation syndrome 肺胞低換気症候群 allograft 同種[他家]移植[片] alveolar lining layer 肺胞被覆層 allotransplantation 異種(異物)移植[法] alveolar liquid clearance 肺胞液クリアランス alternative pulse 交代(互)脈 alveolar macrophage 肺胞大食細胞 altitude 高地 alveolar macrophage 肺胞マクロファージ altitude 高度 alveolar membrane 肺胞膜 altitude 高さ alveolar microlithiasis 肺胞微石症 altitude accommodation 高所順(適)応 alveolar pattern 肺胞[性]パターン altitude adaptation 高所順(適)応 alveolar phagocyte 肺胞食細胞 altitude disease (altitude sickness) (high altitude disease) alveolar plateau 肺胞プラトー(02または指標ガス1回呼吸法での洗い出し曲線 高山病 平坦部分) altitude sickness 高山病 alveolar pore 肺胞孔 aluminosis アルミニウム肺症 alveolar pressure 肺胞圧 aluminum lung アルミニウム肺 alveolar pressure 肺胞内圧 alveolar 肺胞の alveolar proteinosis 肺胞蛋白症 alveolar
Recommended publications
  • USMLE – What's It
    Purpose of this handout Congratulations on making it to Year 2 of medical school! You are that much closer to having your Doctor of Medicine degree. If you want to PRACTICE medicine, however, you have to be licensed, and in order to be licensed you must first pass all four United States Medical Licensing Exams. This book is intended as a starting point in your preparation for getting past the first hurdle, Step 1. It contains study tips, suggestions, resources, and advice. Please remember, however, that no single approach to studying is right for everyone. USMLE – What is it for? In order to become a licensed physician in the United States, individuals must pass a series of examinations conducted by the National Board of Medical Examiners (NBME). These examinations are the United States Medical Licensing Examinations, or USMLE. Currently there are four separate exams which must be passed in order to be eligible for medical licensure: Step 1, usually taken after the completion of the second year of medical school; Step 2 Clinical Knowledge (CK), this is usually taken by December 31st of Year 4 Step 2 Clinical Skills (CS), this is usually be taken by December 31st of Year 4 Step 3, typically taken during the first (intern) year of post graduate training. Requirements other than passing all of the above mentioned steps for licensure in each state are set by each state’s medical licensing board. For example, each state board determines the maximum number of times that a person may take each Step exam and still remain eligible for licensure.
    [Show full text]
  • Ep001476158b1*
    (19) *EP001476158B1* (11) EP 1 476 158 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 31/455 (2006.01) A61P 29/00 (2006.01) 14.11.2007 Bulletin 2007/46 A61P 11/00 (2006.01) C07D 405/12 (2006.01) C07D 213/82 (2006.01) C07D 401/12 (2006.01) (2006.01) (21) Application number: 03739392.3 C07D 451/04 (22) Date of filing: 03.02.2003 (86) International application number: PCT/IB2003/000439 (87) International publication number: WO 2003/068235 (21.08.2003 Gazette 2003/34) (54) NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS NICOTINAMID-DERIVATE ALS PDE4-HEMMER DERIVES DE NICOTINAMIDE UTILES COMME INHIBITEURS DE PDE4 (84) Designated Contracting States: • HENDERSON, A.J., AT BE BG CH CY CZ DE DK EE ES FI FR GB GR c/o UK Patent Dept., HU IE IT LI LU MC NL PT SE SI SK TR Pfizer Ltd. Designated Extension States: Sandwich, Kent CT13 9NJ (GB) AL LT LV MK RO • MAGEE, T.V., c/o Pfizer Global Res. and Develop. (30) Priority: 11.02.2002 GB 0203196 Groton, CT 06340 (US) 10.09.2002 GB 0220999 • MARFAT, A., 21.10.2002 GB 0224453 c/o Pfizer Global Res. and Develop. 20.11.2002 GB 0227139 Groton, CT 06340 (US) • MATHIAS, J.P., (43) Date of publication of application: c/o Pfizer Global Res. and Develop. 17.11.2004 Bulletin 2004/47 Sandwich, Kent CT13 9NJ (GB) (73) Proprietors: • MCLEOD, D.G., • Pfizer Limited c/o Pfizer Global Res.
    [Show full text]
  • CARDINAL SYMPTOMS of HEART DISEASE Exam 1 | Dr. Donato Marañon | September 24, 2012
    OS 213: Cardiovascular System LEC 02: CARDINAL SYMPTOMS OF HEART DISEASE Exam 1 | Dr. Donato Marañon | September 24, 2012 OUTLINE Common Cardiac Symptomatology B. Dyspnea A. Chest Pain C. Palpitations 1. Attributes of Pain D. Edema 2. Definitions E. Cyanosis 3. Chronic Recurrent Chest Pain Syndrome F. Syncope 4. Acute Chest Pain Syndrome II. Importance of History and PE 5. Case Discussion The lecture is similar from block B’s Lecture but we changed the formatting though kasing ang gulo nung topic. So if mas naguluhan kayo sorry. Some changes: 1. All the symptomatology are now under common cardiac symptomatology. 2. Differentials for chest pain have been divided into chronic and acute. I. COMMON CARDIAC SYMPTOMATOLOGY Symptoms: complaints of the patient (most common complaint: pain); Includes chest pain, dyspnea, palpitations, edema, cyanosis, syncope Signs: doctors’ objective findings and observations A. CHEST PAIN Chest pain: most common but not exhaustive - can be caused by other factors such as hypertension ATTRIBUTES OF PAIN (PPQRSTO) Provocative – what provokes/triggers the pain o Is it precipitated by effort (exertional)? o At what time does it appear? When you are trying to get up, moving the body, etc… Palliative – what relieves/palliates the pain o Medications, therapy, etc… Quality – the nature of the pain o Sharp, burning, pricking, stabbing, strangulating, oppressing, ache similar to muscle ache, etc. Region/Radiation – location (primary region where the pain is felt), central region, how wide the coverage is and where the pain radiates or is worst o Central precordial pain where does it radiate? Back? Leg? o Hard to interview Filipinos – “doon, diyan” – vague descriptions of location Severity – intensity: mild, moderate, severe o May use a scale from 0 to 10 (worst) o Give open-ended questions Timing o Onset – abrupt, worse at start, insidious, builds up/gradual Ian, Aca, Hannah UPCM 2016A: XVI, Walang 1 of Kapantay! 14 OS 213: Cardiovascular System LEC 02: CARDINAL SYMPTOMS OF HEART DISEASE Exam 1 | Dr.
    [Show full text]
  • Oral Health and Respiratory Infection
    C LINICAL P RACTICE Oral Health and Respiratory Infection • Philippe Mojon, DMD, PhD • Abstract The oral cavity has long been considered a potential reservoir for respiratory pathogens. The mechanisms of infec- tion could be aspiration into the lung of oral pathogens capable of causing pneumonia, colonization of dental plaque by respiratory pathogens followed by aspiration, or facilitation by periodontal pathogens of colonization of the upper airway by pulmonary pathogens. Several anaerobic bacteria from the periodontal pocket have been isolated from infected lungs. In elderly patients living in chronic care facilities, the colonization of dental plaque by pulmonary pathogens is frequent. Notably, the overreaction of the inflammatory process that leads to destruc- tion of connective tissue is present in both periodontal disease and emphysema. This overreaction may explain the association between periodontal disease and chronic obstructive pulmonary disease, the fourth leading cause of death in the United States. These findings underline the necessity for improving oral hygiene among patients who are at risk and those living in long-term care institutions. MeSH Key Words: aged; periodontal diseases/epidemiology; pneumonia, aspiration/epidemiology; pneumonia, aspiration/ prevention & control © J Can Dent Assoc 2002; 68(6):340-5 This article has been peer reviewed. he anatomical continuity between the lungs and the different for the 2 types. CAP is a frequent illness, with an oral cavity makes the latter a potential reservoir of incidence rate estimated at about 8 cases per 1,000 inhabi- Trespiratory pathogens. Yet an infective agent must tants per year in industrialized countries. The mortality rate defeat sophisticated immunological and mechanical is about 7% in hospitalized patients.1 Streptococcus pneumo- defence mechanisms to reach the lower respiratory tract.
    [Show full text]
  • 179 the Pre-Operative Assessment of Acyanotic Pediatric Patients
    179 ORIGINAL ARTICLE Th e Pre-operative Assessment of Acyanotic Pediatric Patients Presented with Heart Murmur and Role of Surgry in congenital heart diseases, A retrospective analysis Dhafer O Alqahtani, Ali A. Alakfash, Omar R .Altamim Abstract Objectives: Th e aim of this study is to evaluate the incidence of congenital heart disease in patients referred solely because of heart murmur in pediatric age group and to assess the rule of medical and surgical management in patient with heart defects. Study design: It is retrospective analysis of all paediatric cases who presented with cardiac murmur. Materials and Methods:A retrospective database and echocardiographic review. All patients referred to King Abdulaziz Cardiac Center (KA CC) Riyadh, Kingdom of Saudi Arabia dur- ing the period from July 2007 till March 2009 for cardiovascular evaluation because of heart murmur detected during routine physical exam. We included any pediatric patient from the neonatal period till 14 years of age who had echocardiography in our center. Any patient with cyanosis, those with diff erence in the blood pressure between the upper limbs and lower limbs of more than 15 mmHg, preterm neonates, any acquired heart disease and syndromic and critically ill patients were excluded from the study. Results: A total of 245 patients met the inclusion criteria. Median age and weight is 7 months (one day – 12 years), 7.85 Kg (1.9 – 54 Kg) respectively. Normal echocardiography was pres- ent in 163 patients (66.5%). Th e most encountered anomaly found was patent ductus arte- riosious (PDA) which was diagnosed in 27 patients (11 %) followed by atrial septal defect (ASD) secundum in 26 patients (10.6%), then the VSD in 22 patients (9%), atrio-ventricular septal defect (AVSD) in 1 patient (0.4%), Coarctation of Aorta in 3 patients (1.2%), Tortuous of arch in 1 patients (0.4%), Pulmonary stenosis in 10 patients (4%), Mitral valve prolapse in 4 patients (1.6%) and the false tendon in 6 patients (2.4 %).
    [Show full text]
  • Orthopnea : Dyspnoea on Supine Position
    PRESENTED BY Dr . G . Subrahmanyam M.D., D.M., Professor of Cardiology Director of Narayana Medical Institutions Ex-Professor of Cardiology SVMC &SVRRH Ex Asst. Professor of Medicine, SVMC & SVRRH S CSSCLASS RANKS BAGGED . DURING 2010 1 FIRST M.B.B.S 1ST, 2ND, 3RD &5TH 2 SECOND M. B. B. S 4TH, 5TH, 6TH &10& 10TH 3 THIRD PART-I 1ST & 9TH 4 THRID PART-II 5th, 8th, 10TH NARAYANA NURSING INSTITUTION S.NO RANKS OBTAINED IN M.Sc(Nursing) during 2010 11st,2nd,3rd, 4th,5th, 6th,7th, 8th NARAYANA PHARMACY COLLEGE NARAYANA DENTAL COLLEGE • In MDS results, 27 out of 28 students passed successfully. • MDS(Prostodontics) is the topper in the University wide during 2010. • The only centre in AP with all the Superspecialities like M. CH( Surgical gastro enterology). • History will give you likely diagnosis over 75% of the time • DO NOT SKIP IT in favour of tests • History will help you immediately – Test s will ta ke time to come bac k an d may resu lt in more questions than answers. Best in the physician’s Quer History is the richest source of information Patient spouse gives good information (Chyne stokes respiration) His tory : 1G1. Genera lMdilHitl Medical History 2. Personal and past history 3. Occupational history 4. Nutritional history DYSPNOEA • Dyspnoea on Exercise • Dyspnoea on deconditioning Normal person. But moderate exercise unaccumastomed causes Dyspnoea • Interstial and alveolar oedema stretches ‘J’ receptors in the lung (CCF) ↓cardiac output (TOF) without lung congestion. Inspiratory Dyspnoea : Obstructive airway disease. Expiratory Dyspnoea: Obstruction to lower airways Exertional Dyspnoea : COPD, Cardiac failure Dyspnoea developing at rest Pheumothorax PlPul.em blibolism Dyspnoea occuring at rest and absent on exertion : Functional DYSPNOEA Cardiac, Renal, Ovarian, Bronchial, Psychogenic Postural – Myxoma Squatting ↓ Tof Trepopnea : Lateral position occurs eg.
    [Show full text]
  • Diffuse Alveolar Hemorrhage Syndrome Secondary to Bocavirus
    Case report Diffuse alveolar hemorrhage syndrome secondary to bocavirus and rhinovirus infection in a pediatric patient Síndrome de hemorragia alveolar difusa secundaria a coinfección por Rhinovirus y Bocavirus en un paciente pediátrico Carlos Eduardo Reina1 , Sandra Patricia Concha2, Rubén Eduardo Lasso2, Fernando Bermúdez2, María Teresa Agudelo3 Abstract The diffuse alveolar hemorrhage syndrome is characterized by the presence of blood in the pulmonary alveolus from arterioles, venules and pulmonary Date correspondence: capillaries, as a consequence of the lesion of the alveolar wall and without an Received: February 20, 2015. endobronchial alteration. Its presentation includes a classic triad of hemopty- Revised: September 11, 2017. sis, anemia and diffuse alveolar infiltrates. It´s a rare but potentially fatal entity Accepted: October 31, 2017. and there are no clear data on its real incidence in the pediatric population. We present the case of a previously healthy pediatric patient, immunocompetent, How to cite: who presented diffuse alveolar hemorrhage syndrome with secondary venti- Reina CE, Concha SP, Lasso RE, latory failure. After discarding all possible etiologies, coinfection by Rhinovirus Bermudez F, Agudelo MT. Diffuse and human Bocavirus was detected through the polymerase chain reaction, alveolar hemorrhage syndrome determining them as causal factors of the event. Recently, viral infections secondary to Rhinovirus and have been postulated as causing serious lung disease, especially coinfec- Bocavirus coinfection in a tion in immunocompromised patients, in this case Rhinovirus and human pediatric patient. Rev CES Bocavirus; however there are no reports on the syndrome caused by these Medicina. 2018; 32(1): 53-60. viruses. Open access Keywords: Diffuse alveolar hemorrhage; Respiratory failure; Rhinovirus; © Derecho de autor Human Bocavirus.
    [Show full text]
  • Subclinical Subaortic Stenosis in a Golden Retriever
    CASE ROUTES h CARDIOLOGY h PEER REVIEWED Subclinical Subaortic Stenosis in a Golden Retriever Kursten Pierce, DVM, DACVIM (Cardiology) Colorado State University THE CASE THE CASE A 12-month-old intact female golden retriever is pre- Diagnostic investigation of the heart murmur via echo- sented for a wellness examination and to discuss the cardiography is discussed with the owner but declined pros and cons of breeding the patient versus pursuing due to the patient’s lack of clinical signs and the costs ovariohysterectomy. The owner would like her to pro- associated with additional testing. duce one litter of puppies prior to being spayed. What are the next steps? On physical examination, the patient is bright, alert, and responsive. She is extremely energetic with a good THE CHOICE IS YOURS … BCS (4/9) and appropriate musculature. Cardiovascu- CASE ROUTE 1 lar examination reveals pink mucous membranes, no To provide information on breeding and caring for a obvious jugular venous distension, and a normal heart pregnant bitch and neonatal puppies and plan to spay rate and rhythm with normal synchronous femoral the patient after the puppies have been weaned, go to pulses. Auscultation is difficult and brief because the page 28. patient is rambunctious and panting. Despite the pant- ing, she is eupneic with clear bronchovesicular sounds. CASE ROUTE 2 A grade II/VI left basilar systolic heart murmur is aus- To avoid providing additional recommendations cultated. A murmur had not previously been docu- regarding breeding and ovariohysterectomy to the mented at her puppy wellness visits. The owner has not owner until a diagnostic investigation with a cardiolo- observed any coughing, trouble breathing, exercise gist has been pursued, go to page 32.
    [Show full text]
  • Lipid–Protein and Protein–Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis
    International Journal of Molecular Sciences Review Lipid–Protein and Protein–Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis Olga Cañadas 1,2,Bárbara Olmeda 1,2, Alejandro Alonso 1,2 and Jesús Pérez-Gil 1,2,* 1 Departament of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University, 28040 Madrid, Spain; [email protected] (O.C.); [email protected] (B.O.); [email protected] (A.A.) 2 Research Institut “Hospital Doce de Octubre (imasdoce)”, 28040 Madrid, Spain * Correspondence: [email protected]; Tel.: +34-913944994 Received: 9 May 2020; Accepted: 22 May 2020; Published: 25 May 2020 Abstract: Pulmonary surfactant is a lipid/protein complex synthesized by the alveolar epithelium and secreted into the airspaces, where it coats and protects the large respiratory air–liquid interface. Surfactant, assembled as a complex network of membranous structures, integrates elements in charge of reducing surface tension to a minimum along the breathing cycle, thus maintaining a large surface open to gas exchange and also protecting the lung and the body from the entrance of a myriad of potentially pathogenic entities. Different molecules in the surfactant establish a multivalent crosstalk with the epithelium, the immune system and the lung microbiota, constituting a crucial platform to sustain homeostasis, under health and disease. This review summarizes some of the most important molecules and interactions within lung surfactant and how multiple lipid–protein and protein–protein interactions contribute to the proper maintenance of an operative respiratory surface. Keywords: pulmonary surfactant film; surfactant metabolism; surface tension; respiratory air–liquid interface; inflammation; antimicrobial activity; apoptosis; efferocytosis; tissue repair 1.
    [Show full text]
  • Sudan's Guidelines for Diagnosis, Management and Prevention
    Acute Rheumatic Fever and Rheumatic Heart Disease: Sudan’s Guidelines for Diagnosis, Management and Prevention 1 2 Sudan’s Federal Ministry of Health Sudan Heart Society-Working Group on Pediatric Cardiology Sudanese Association of Pediatricians Sudanese Children’s Heart Society Writing Committee: Sulafa Khalid M Ali, FRCPCH, FACC, Consultant Pediatric Cardiologist Professor-University of Khartoum Mohamed Saeed Al Khaleefa, FRCP, Consultant Cardiologist Professor-University of Al Zaem Al Azhari Siragedeen Mohamed Khair, MD, Consultant Pediatrician Professor- University of Al Zaem Al Azhari Second Edition Jan/2017 3 Contents Chapter Title Page Preface 5 Chapter 1 Rheumatic Heart Disease : General Considerations 6 Chapter 2 Diagnosis and Management of Streptococcal 11 Pharyngitis Chapter 3 Acute Rheumatic Fever 15 Chapter 4 Rheumatic Heart Disease 25 Chapter 5 Rheumatic Heart Disease in Pregnancy 49 Chapter 6 Acute Rheumatic Fever & Rheumatic Heart Disease 57 Control Appendices Rheumatic Heart Disease Protocols, Manuals, 63 Brochures and Educational Websites 4 Preface to the Second Edition: This is the second edition of Sudan’s Guidelines for acute rheumatic fever (ARF) and rheumatic heart disease (RHD) diagnosis, management and prevention. RHD is a devastating sequel of ARF, initiated by a simple throat infection with group A streptococcus in susceptible population. Eradication of RHD can be achieved by improvement of health care system as has been witnessed in developed countries. In many developing countries like Sudan, RHD is still prevalent causing significant mortality and premature cardiovascular death as well as an undesired burden on the health system. An RHD control program has been established in Sudan in 2012 aiming to increase the awareness of both the public and medical personnel, to introduce primary and consolidate secondary prevention and to strengthen the surveillance system.
    [Show full text]
  • Distribution of Bronchial Gland Measurements in a Jamaican Population
    Thorax: first published as 10.1136/thx.24.5.619 on 1 September 1969. Downloaded from Thorax (1969), 24, 619. Distribution of bronchial gland measurements in a Jamaican population J. A. HAYES1 From the Pathology Department, University of the West Indies, Mona, Kingston 7, Jamaica Measurements of the gland thickness and Reid index have been made on bronchi obtained at necropsy on 53 male and 52 female Jamaicans. The mean values for the Reid index and mucous gland thickness obtained were 0-314 and 0O192 mm. for males, and 0-302 and 0l170 mm. for females respectively. No significant increase in value was seen with age, although the data suggest this trend. The results have been compared with data published from Montreal and the same overall Gaussian distribution is seen. This supports the suggestion that the gland measurements in non-bronchitic and bronchitic subjects do- not fall into two distinct groups but are part of a continuous distribution. The similarity of the two studies is also of interest as the populations are drawn from two distinct environments, one from a non-industrialized tropical island, the other from a large city in the northern hemisphere. Bronchial mucous gland enlargement is usually The existing evidence, therefore, indicates that associated with the consistent production of atmospheric pollution is connected with enlarge- copyright. mucoid sputum in chronic bronchitis (Reid, 1958). ment of bronchial mucous glands. It was suggested that this mucosal change could Clinical chronic bronchitis is encountered in be recognized by an increase in the ratio of Jamaica, apparently in the absence of atmospheric mucous gland thickness to thickness of the pollution (Walshe and Hayes, 1967).
    [Show full text]
  • Respiratory System
    RESPIRATORY SYSTEM Dept.Dept. ofof HistologyHistology andand EmbryologyEmbryology 周莉周莉 教授教授 Respiratory System Nose Pharynx Larynx Trachea Bronchus Lung NASAL CAVITY 1. Mucosa:epithelium and lamina propria 1.1 Vestibular Region: 1.2 Respiratory Region: pseudostratified ciliated columnar epithelium, mixture glands (nasal glands), abundant blood vessels and lymphoid tissue in lamina propria 1.3 Olfactory Region (1) Olfactory epithelium: pseudostratified ciliated columnar epithelium A. supporting cells B. olfactory cells C. basal cells (2) Lamina Propria: olfactory glands (serous type) Olfactory epithelium TRACHEA AND BRONCHUS Mucosa: Pseudostratified ciliated columnar epiothelium Lamina propia Submucosa:LCT Advantitia: cartilage tissue and CT 1. Mucosa 1.11.1 PseudostratifiedPseudostratified ciliatedciliated columnarcolumnar epitheliumepithelium (1)(1) ciliatedciliated cellscells (2)(2) gobletgoblet cellscells (3)(3) basalbasal cellscells (4)(4) brushbrush cellscells (5)(5) diffusediffuse neuroendocrineneuroendocrine cellscells (small(small granulegranule cells)cells) Tracheal Sueface (SEM) Pseudostratified ciliated columnar epithelium(LM) 1.21.2 LaminaLamina PropriaPropria ThickThick basementbasement membrane,membrane, CTCT,, immuneimmune cellscells 2.2. SubmucosaSubmucosa::LCTLCT TrachealTracheal glandsglands (( mixturemixture type)type),, mucousmucous barrierbarrier lymphoidlymphoid tissuetissue thethe effectseffects ofof sIgAsIgA Tracheal wall 3. Advantitia C- shaped rings of hyaline cartilage and LCT membrane portion:ligament rich in
    [Show full text]